Equity Profile

MASI

Masimo Corporation

Health CareHealth Care Equipment$9.4B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Masimo Corporation is a healthcare technology company that develops innovative non-invasive monitoring solutions. With a market cap of $9 billion, it plays a crucial role in improving patient outcomes through advanced medical devices, particularly in the health care equipment sector.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the demand for Masimo's products and overall business performance.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

MASI Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

-28.73%

Avg Stock Reaction

+1.41%

Last Quarter Recap

In Q1 2026, Masimo reported an EPS of $1.09, falling short of expectations by 22.7%. The stock experienced a slight increase of 0.21% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Masimo's upcoming earnings are uncertain due to the lack of analyst estimates and mixed historical performance.

Bull Case

An optimistic view suggests that Masimo could surprise investors with strong revenue growth and improved profitability, potentially leading to a significant stock price increase.

Bear Case

Conversely, there are concerns that continued underperformance in EPS and revenue could lead to further declines in stock value.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth for Masimo's key monitoring products?

Revenue growth will be a critical indicator of demand for Masimo's products and overall business health.

Will EPS meet or exceed expectations this quarter?

Given the recent EPS misses, the market will be closely watching for any signs of improvement in profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Masimo's potential for recovery, especially given the recent focus on non-invasive monitoring solutions in healthcare.

Supporting Evidence

The options market is pricing in a move that suggests higher volatility than what has been historically realized.

Masimo's innovative product pipeline could lead to unexpected revenue growth that analysts are not factoring in.

Key Risk

If Masimo can demonstrate a significant uptick in product demand, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is under scrutiny due to previous earnings misses and the need for a turnaround in financial metrics.

Bull Confirmed If

A revenue growth rate of over 10% would confirm a strong demand for Masimo's products.

Bear Confirmed If

An EPS below $1.00 would indicate ongoing profitability issues.

Pre-Earnings Positioning

Options Market

Implied Move

±2.72%

Historical Avg

±1.8%

Pricing rich

The options market is pricing in a moderate move of approximately 2.72%, suggesting that investors expect some volatility around the earnings announcement.

Options are pricing ±2.7% while MASI has averaged ±1.8% over the last 8 prints — setup is pricing rich.

Detail

30d HV

1.4%

Calls (3K)P/C Ratio: 0.02Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Masimo beats expectations, history suggests a potential stock increase of around 1.83%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future guidance.

Miss

A miss could lead to a decline of approximately 0.14%, reinforcing bearish sentiment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market demand for non-invasive monitoring solutions.
3Insights into cost management and profitability improvements.
4Guidance on future earnings expectations and growth strategies.
5Responses to competitive pressures in the healthcare equipment sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the demand for Masimo's products and overall business performance.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

MASI Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

-28.73%

Avg Stock Reaction

+1.41%

Last Quarter Recap

In Q1 2026, Masimo reported an EPS of $1.09, falling short of expectations by 22.7%. The stock experienced a slight increase of 0.21% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Masimo's upcoming earnings are uncertain due to the lack of analyst estimates and mixed historical performance.

Bull Case

An optimistic view suggests that Masimo could surprise investors with strong revenue growth and improved profitability, potentially leading to a significant stock price increase.

Bear Case

Conversely, there are concerns that continued underperformance in EPS and revenue could lead to further declines in stock value.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth for Masimo's key monitoring products?

Revenue growth will be a critical indicator of demand for Masimo's products and overall business health.

Will EPS meet or exceed expectations this quarter?

Given the recent EPS misses, the market will be closely watching for any signs of improvement in profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Masimo's potential for recovery, especially given the recent focus on non-invasive monitoring solutions in healthcare.

Supporting Evidence

The options market is pricing in a move that suggests higher volatility than what has been historically realized.

Masimo's innovative product pipeline could lead to unexpected revenue growth that analysts are not factoring in.

Key Risk

If Masimo can demonstrate a significant uptick in product demand, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is under scrutiny due to previous earnings misses and the need for a turnaround in financial metrics.

Bull Confirmed If

A revenue growth rate of over 10% would confirm a strong demand for Masimo's products.

Bear Confirmed If

An EPS below $1.00 would indicate ongoing profitability issues.

Pre-Earnings Positioning

Options Market

Implied Move

±2.72%

Historical Avg

±1.8%

Pricing rich

The options market is pricing in a moderate move of approximately 2.72%, suggesting that investors expect some volatility around the earnings announcement.

Options are pricing ±2.7% while MASI has averaged ±1.8% over the last 8 prints — setup is pricing rich.

Detail

30d HV

1.4%

Calls (3K)P/C Ratio: 0.02Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Masimo beats expectations, history suggests a potential stock increase of around 1.83%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future guidance.

Miss

A miss could lead to a decline of approximately 0.14%, reinforcing bearish sentiment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market demand for non-invasive monitoring solutions.
3Insights into cost management and profitability improvements.
4Guidance on future earnings expectations and growth strategies.
5Responses to competitive pressures in the healthcare equipment sector.